Ten years of image analysis and machine learning competitions in dementia
@article{Bron2022TenYO, title={Ten years of image analysis and machine learning competitions in dementia}, author={Esther E. Bron and Stefan Klein and Annika Reinke and Janne M. Papma and Lena Maier-Hein and Daniel C Alexander and Neil P. Oxtoby}, journal={NeuroImage}, year={2022}, volume={253} }
References
SHOWING 1-10 OF 60 REFERENCES
Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer’s disease dementia: a systematic review
- Psychology, MedicineAlzheimer's research & therapy
- 2021
A systematic review of studies where machine learning was applied to neuroimaging data in order to predict whether patients with mild cognitive impairment might develop Alzheimer’s disease dementia or remain stable found this methodology has a great potential as a support tool for clinicians and healthcare professionals.
Gray Matter Age Prediction as a Biomarker for Risk of Dementia
- PsychologyProceedings of the National Academy of Sciences
- 2019
The gap between predicted and chronological brain age is a biomarker, complimentary to those that are known, associated with risk of dementia, and could possibly be used for early-stage dementia risk screening.
A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages
- BiologyNeuroImage
- 2017
Predicting the Progression of Mild Cognitive Impairment Using Machine Learning: A Systematic and Quantitative Review
- Psychology
- 2019
Context. Automatically predicting if a subject with Mild Cognitive Impairment (MCI) is going to progress to Alzheimer's disease (AD) dementia in the coming years is a relevant question regarding…
Convolutional Neural Networks for Classification of Alzheimer's Disease: Overview and Reproducible Evaluation
- Computer ScienceMedical Image Anal.
- 2020
Imaging plus X: multimodal models of neurodegenerative disease
- BiologyCurrent opinion in neurology
- 2017
It is argued that the time is approaching for data-driven disease modelling to take centre stage in the study and management of neurodegenerative disease, and this will make disease progression modelling invaluable for recruitment and end-points in future clinical trials, potentially ameliorating the high failure rate in trials of, e.g., Alzheimer's disease therapies.
Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review.
- PsychologyMedical image analysis
- 2020
Looking for Alzheimer's Disease morphometric signatures using machine learning techniques
- Medicine, Computer ScienceJournal of Neuroscience Methods
- 2018
Clinical Prediction from Structural Brain MRI Scans: A Large-Scale Empirical Study
- PsychologyNeuroinformatics
- 2014
The results suggest that the biological footprint (effect size) has a dramatic influence on prediction performance, and cross-validation estimates of performance, while generally optimistic, correlate well with generalization accuracy on a new dataset.
Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge
- PsychologyNeuroImage
- 2015